Paper Titles in Periodical
International Letters of Chemistry, Physics and Astronomy
Volume 51
Subscribe

Subscribe to our Newsletter and get informed about new publication regulary and special discounts for subscribers!

ILCPA > Volume 51 > Synthesis and In Vitro Antimicrobial Activity of...
< Back to Volume

Synthesis and In Vitro Antimicrobial Activity of 3-(5-((2-Oxo-2H-Chromen-4-yl)Thio)-4-Phenyl-Thiazol-2-yl)-2-Substitutedphenyl Thiazolidin-4-One

Full Text PDF

Abstract:

An array of 3-(5-((2-oxo-2H-chromen-4-yl) thio)-4-phenyl thiazol-2-yl)-2-substitutedphenyl thiazolidin-4-one (7a-j) have been synthesized by using acetophenone, thiourea, 4-mercaptocoumarin and thioglycolic acid. The structures of these compounds were confirmed by IR, 1H NMR, 13C NMR and mass analysis. All the newly synthesized derivatives were evaluated for their in vitro antibacterial activity (against E. coli, P. aeruginosa, S. aureus, S. pyogenes) and antifungal activity against (C. albicans, A. niger, A. clavatus) using broth dilution technique. Some of the compounds showed good to moderate activity against the specific microbial strain.

Info:

Periodical:
International Letters of Chemistry, Physics and Astronomy (Volume 51)
Pages:
135-143
Citation:
H. R. Prajapati et al., "Synthesis and In Vitro Antimicrobial Activity of 3-(5-((2-Oxo-2H-Chromen-4-yl)Thio)-4-Phenyl-Thiazol-2-yl)-2-Substitutedphenyl Thiazolidin-4-One", International Letters of Chemistry, Physics and Astronomy, Vol. 51, pp. 135-143, 2015
Online since:
May 2015
Export:
Distribution:
References:

[1] M. Abhinit, M. Ghodke, N. A. Pratima, International Journal of Pharmacy and Pharmaceutical Sciences 1 (2009) 47.

[2] S. P. Singh, S. S. Parmar, K. Raman, V. I. Stenberg, Chemical reviews 81 (1981) 175.

[3] P. Mehta, P. Dawedra, V. Goswami, H. S. Joshi, International Letters of Chemistry, Physics and Astronomy 11 (2014) 1.

[4] A. D. Taranalli, A. R. Bhat, S. Srinivas, E. Saravanan, Indian Journal of Pharmaceutical Sciences 70 (2008) 159.

[5] N. Karalı, A. Gürsoy, F. Kandemirli, N. Shvets, F. B. Kaynak, S. Özbey, V. Kovalishyn, A. Dimoglo, Bioorganic & Medicinal Chemistry 15 (2007) 5888.

DOI: https://doi.org/10.1016/j.bmc.2007.05.063

[6] D. Kaminskyy, B. Bednarczyk-Cwynar, O. Vasylenko, O. Kazakova, B. Zimenkovsky, L. Zaprutko, R. Lesyk, Medicinal Chemistry Research 21 (2012) 3568.

DOI: https://doi.org/10.1007/s00044-011-9893-9

[7] S. Wang, Y. Zhao, W. Zhu, Y. Liu, K. Guo, P. Gong, Archiv der Pharmazie 345 (2012) 73.

[8] D. Havrylyuk, B. Zimenkovsky, O. Vasylenko, A. Gzella, R. Lesyk, Journal of Medicinal Chemistry 55 (2012) 8630.

[9] J. Balzarini, B. Orzeszko-Krzesińska, J. K. Maurin, A. Orzeszko, European journal of medicinal chemistry 44 (2009) 303.

DOI: https://doi.org/10.1016/j.ejmech.2008.02.039

[10] V. S. Palekar, A. J. Damle, S. Shukla, European journal of medicinal chemistry 44 (2009) 5112.

[11] K. Omar, A. Geronikaki, P. Zoumpoulakis, C. Camoutsis, M. Soković, A. Ćirić, J. Glamočlija, Bioorganic & Medicinal Chemistry 18 (2010) 426.

DOI: https://doi.org/10.1016/j.bmc.2009.10.041

[12] M. -H. Shih, F. -Y. Ke, Bioorganic & Medicinal Chemistry 12 (2004) 4633.

[13] E. Tatar, İ. Küçükgüzel, E. De Clercq, F. Şahin, M. Guelluece, Arkivoc 14 (2008) 191.

[14] F. Ragab, N. M. Eid, H. El-Tawab, Die Pharmazie 52 (1997) 926.

[15] A. Srinivas, A. Nagaraj, C. Sanjeeva Reddy, Journal of Heterocyclic Chemistry 46 (2009) 497.

[16] M. V. Diurno, O. Mazzoni, E. Piscopo, A. Calignano, F. Giordano, A. Bolognese, Journal of Medicinal Chemistry 35 (1992) 2910.

[17] D. Sriram, P. Yogeeswari, T. Kumar, Journal of Pharmacy & Pharmaceutical Sciences 8 (2005) 426.

[18] V. G. Bhila, Y. L. Chovatiya, C. V. Patel, R. R. Giri, D. I. Brahmbhatt, International Letters of Chemistry, Physics and Astronomy 1 (2015).

Show More Hide
Cited By:
This article has no citations.